Genetic Variation in the α7 Nicotinic Acetylcholine Receptor is Associated with Delusional Symptoms in Alzheimer's Disease

被引：32

作者：

Carson, Robyn ^{[1
]}

Craig, David ^{[1
]}

Hart, Dominic ^{[1
]}

Todd, Stephen ^{[1
]}

McCuinness, Bernadette ^{[1
]}

Johnston, Janet A. ^{[1
]}

O'Neill, Francis A. ^{[1
]}

Ritchie, Craig W. ^{[2
]}

Passmore, A. Peter ^{[1
]}

机构：

[1] Queens Univ Belfast, Sch Med & Dent, Div Psychiat & Neurosci, Belfast BT9 7BL, Antrim, North Ireland

[2] Univ London Imperial Coll Sci Technol & Med, Div Neurosci, Claybrook Ctr, London W6 8LN, England

来源：

NEUROMOLECULAR MEDICINE | 2008年 / 10卷 / 04期

关键词：

CHRNA7; Haplotype; Polymorphism; Psychosis; Delusions; Hallucinations;

D O I：

10.1007/s12017-008-8048-8

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Psychotic symptoms are common in Alzheimer's disease (AD) and have a negative impact oil quality of life. It is suggested that psychotic symptoms may be attributed to genetic risk factors which are revealed during neurodegeneration. CHRNA7, the gene for the alpha 7 nicotinic acetylcholine receptor, has been associated with schizophrenia in linkage and association Studies. Hence we investigated single SNPs and haplotypes in CHRNA7 in relation to AD with psychosis in a large, well-characterised and previously described cohort within the Northern Ireland population. A significant association between delusions and the T allele of rs6494223 (P = 0.014, OR = 1.63, Cl 1.22-2.17) was found. This suggests that the alpha 7 receptor may be a suitable target for the treatment of AD with psychosis.

引用

页码：377 / 384

页数：8

共 50 条

[1] Genetic Variation in the α7 Nicotinic Acetylcholine Receptor is Associated with Delusional Symptoms in Alzheimer’s Disease
Robyn Carson
David Craig
Dominic Hart
Stephen Todd
Bernadette McGuinness
Janet A. Johnston
Francis A. O’Neill
Craig W. Ritchie
A. Peter Passmore
NeuroMolecular Medicine, 2008, 10 : 377 - 384
[2] Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes
Teaktong, T
Graham, A
Court, J
Perry, R
Jaros, E
Johnson, M
Hall, R
Perry, E
GLIA, 2003, 41 (02) : 207 - 211
[3] Association analysis of the partially duplicated α7 nicotinic acetylcholine receptor genetic variant and Alzheimer's disease
Liou, YJ
Lai, IC
Hong, CJ
Liu, HC
Liu, TY
Tsai, SJ
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (05) : 301 - 304
[4] Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease
Singh, Sushma
Agrawal, Neetu
Goyal, Ahsas
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (03) : 384 - 394
[5] α7 Nicotinic acetylcholine receptor gene and reduced risk of Alzheimer's disease
Carson, R.
Craig, D.
McGuinness, B.
Johnston, J. A.
O'Neill, F. A.
Passmore, A. P.
Ritchie, C. W.
JOURNAL OF MEDICAL GENETICS, 2008, 45 (04) : 244 - 248
[6] Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease
Ma, Kai-Ge
Qian, Yi-Hua
NEUROPEPTIDES, 2019, 73 : 96 - 106
[7] Ab NEUROTOXICITY AND THE ROLE OF THE α7 NICOTINIC ACETYLCHOLINE RECEPTOR IN ALZHEIMER'S DISEASE
Small, D. H.
JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 185 - 186
[8] The nicotinic acetylcholine receptor, smoking, and Alzheimer's disease
Sabbagh, Marwan N.
Lukas, Ronald J.
Sparks, D. Larry
Reid, Richard T.
JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (04) : 317 - 325
[9] Role of Aβ and the α7 nicotinic acetylcholine receptor in regulating synaptic plasticity in Alzheimer's disease
Small, DH
Fodero, LR
Losic, D
Chu, C
Aguilar, MI
Martin, LL
Chebib, M
LETTERS IN PEPTIDE SCIENCE, 2003, 10 (5-6): : 401 - 404
[10] Does α7 nicotinic acetylcholine receptor play a role in the pathophysiology of Alzheimer's disease?
Dziewczapolski, Gustavo
Masliah, Eliezer
Heinemann, Stephen
BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) : SMA37 - SMA37

← 1 2 3 4 5 →